EUA
Solana SARS-CoV-2 Assay
FDA Emergency Use Authorization · Quidel Corporation · May 5, 2022
Key facts
| Product | Solana SARS-CoV-2 Assay |
|---|---|
| Company | Quidel Corporation |
| Product type | Isothermal Reverse Transcriptase - Helicase-Dependent Amplification (RT-HDA), Single Target |
| Date | May 5, 2022 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: